$40MOpentrons Series E, led by Avego
95%Fewer manual fixes in Waters' AI pilot
500,000Empower software users, per Waters
Platforms & Product
Waters puts AI behind a paywall
AI peak integration for Empower cut manual fixes from 90 to 4 in a pilot. It's subscription-only, with validated deployment expected mid-2027.
Read the full story →Genedata launches an integrated ELN
The Danaher-owned vendor has built a notebook, LIMS and sample management into its biologics R&D platform, moving into ground Benchling and others already hold.
Read the full story →Why it matters: incumbents are turning AI into upsell revenue on software labs already run, so expansion selling matters as much as new logos.
Funding & M&A
Opentrons raises $40M Series E
Led by Avego, the money goes into software, data and AI-run experiments on its lab robots. It has more than 11,000 robots deployed.
Read the full story →Leadership Moves
IntegriChain
Chris Hare, formerly Chief Growth and Revenue Officer at Intelerad, is the new Chief Revenue Officer at the Nordic Capital-backed pharma commercialisation platform.
Read the full story →Talent Insight
Expansion revenue is the new battleground
- Paid AI tiers on existing software shift the weight from new-logo AEs to account managers and CS who can expand accounts.
- Validated AI in GxP labs needs application scientists who can win over QA, not just impress R&D.
- At CRO level: boards keep asking for people who sold to pharma first and scaled SaaS second. It's a small pool.
Building a team in Life Science Software?
Jack Maclean specialises in Life Science Software hiring at QP Group. Talk to Jack about the market, salaries or a search.
Jack MacleanCo-founder · Life Science Software